• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板中基质金属蛋白酶-2 和 -9 的起源。

On the origin of matrix metalloproteinase-2 and -9 in blood platelets.

机构信息

Department of Medical Laboratory Diagnostics, Wroclaw Medical University, Wroclaw, Poland.

出版信息

Platelets. 2012;23(6):467-74. doi: 10.3109/09537104.2012.682103. Epub 2012 May 30.

DOI:10.3109/09537104.2012.682103
PMID:22646815
Abstract

To date, several matrix metalloproteinases (MMPs) have been identified in human platelets. In most research studies, the platelets are obtained using the isolation method from plasma by centrifugation and washing. The metalloproteinase content in the platelets can be affected by the isolation technique and the leukocyte contamination. In this work, we studied the influence of the isolation method on the detection of platelet MMPs and explore the expression of these enzymes in megakaryoblastic MEG-01 cells. We investigated the expression of mRNAs encoding for MMP-2 and -9 in platelets and MEG-01 cells. Using gelatin zymography and western blotting, we examined the expression and release of MMP-2 and 9 by platelets and MEG-01 cells and checked whether the amount of the released MMPs depends on the volume of tested platelet and leukocyte contamination. To investigate the MMP-2 expression profile, we used zymography and flow cytometry. Platelets, in contrast to the MEG-01 cells, neither contain mRNA for MMP-2 nor -9. The platelets contain pro-MMP-2 and release it during the activation. The population of uncontaminated (leukocytes<0.02%) platelets contained no MMP-9 or the active form of MMP-2. We have observed that the activity of MMP-2 in platelet lysate is proportional to their mean volume and that the MMP-2 activity may not be detected if very small platelets are examined. We conclude that the detection of gelatinases in platelets depends on platelet isolation techniques and the degree of leukocyte contamination.

摘要

迄今为止,已在人类血小板中鉴定出几种基质金属蛋白酶(MMPs)。在大多数研究中,通过离心和洗涤从血浆中使用分离方法获得血小板。血小板中的金属蛋白酶含量可能会受到分离技术和白细胞污染的影响。在这项工作中,我们研究了分离方法对血小板 MMPs 检测的影响,并探索了这些酶在巨核细胞系 MEG-01 细胞中的表达。我们研究了编码 MMP-2 和 MMP-9 的 mRNA 在血小板和 MEG-01 细胞中的表达。使用明胶酶谱法和 Western blot,我们检查了血小板和 MEG-01 细胞中 MMP-2 和 9 的表达和释放,并检查了释放的 MMPs 的量是否取决于测试血小板的体积和白细胞污染的程度。为了研究 MMP-2 的表达谱,我们使用了酶谱法和流式细胞术。与 MEG-01 细胞相反,血小板既不含有 MMP-2 的 mRNA,也不含有 MMP-9。血小板含有前-MMP-2 并在激活时释放它。未受污染(白细胞<0.02%)的血小板群既不含有 MMP-9,也不含有活性形式的 MMP-2。我们观察到血小板裂解物中 MMP-2 的活性与它们的平均体积成正比,如果检查非常小的血小板,则可能无法检测到 MMP-2 的活性。我们得出结论,血小板中明胶酶的检测取决于血小板分离技术和白细胞污染的程度。

相似文献

1
On the origin of matrix metalloproteinase-2 and -9 in blood platelets.血小板中基质金属蛋白酶-2 和 -9 的起源。
Platelets. 2012;23(6):467-74. doi: 10.3109/09537104.2012.682103. Epub 2012 May 30.
2
Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.血小板可溶性 CD40L 和基质金属蛋白酶 9 活性是白塞病患者的促炎介质。
Thromb Haemost. 2012 Jan;107(1):88-98. doi: 10.1160/TH11-08-0556. Epub 2011 Nov 24.
3
Release of matrix metalloproteinases-1 and -2, but not -9, from activated platelets measured by enzyme-linked immunosorbent assay.通过酶联免疫吸附试验测定激活血小板中基质金属蛋白酶-1 和 -2 的释放,但不包括 -9。
Platelets. 2011;22(8):572-8. doi: 10.3109/09537104.2011.583300. Epub 2011 Jul 14.
4
Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.一氧化氮抑制会增加主动脉壁基质金属蛋白酶-9的表达。
J Surg Res. 2002 May 1;104(1):15-21. doi: 10.1006/jsre.2002.6396.
5
Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.红酒中的多酚类化合物通过直接抑制血管平滑肌细胞中的1型膜基质金属蛋白酶,强烈抑制凝血酶诱导的前基质金属蛋白酶-2的表达及其激活。
Circulation. 2004 Sep 28;110(13):1861-7. doi: 10.1161/01.CIR.0000142617.52881.F4. Epub 2004 Sep 13.
6
Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2.基质金属蛋白酶-9和-2对血小板聚集的差异调节
Thromb Haemost. 1999 Dec;82(6):1730-5.
7
Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.基质金属蛋白酶-2和-9及其抑制剂金属蛋白酶组织抑制剂-1和-2在人前列腺基质细胞和上皮细胞原代培养物中的表达
J Cell Physiol. 2002 May;191(2):208-16. doi: 10.1002/jcp.10092.
8
Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.细胞外基质金属蛋白酶诱导剂(CD147)是血小板上一种新型受体,可激活血小板,并增强单核细胞中核因子κB依赖性炎症反应。
Circ Res. 2008 Feb 15;102(3):302-9. doi: 10.1161/CIRCRESAHA.107.157990. Epub 2007 Nov 29.
9
Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin.血小板在人体血管损伤部位可在体内释放活性基质金属蛋白酶-2:阿司匹林无法抑制其释放。
Br J Haematol. 2007 Jul;138(2):221-30. doi: 10.1111/j.1365-2141.2007.06632.x.
10
Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.基质金属蛋白酶9通过可溶性CD40配体的释放参与克罗恩病相关的血小板过度活化。
Gut. 2009 Jul;58(7):920-8. doi: 10.1136/gut.2008.150318. Epub 2008 Nov 27.

引用本文的文献

1
The Effect of Leukocyte Removal and Matrix Metalloproteinase Inhibition on Platelet Storage Lesions.白细胞去除和基质金属蛋白酶抑制对血小板储存损伤的影响。
Cells. 2024 Mar 13;13(6):506. doi: 10.3390/cells13060506.
2
Sub-Cellular Localization of Metalloproteinases in Megakaryocytes.巨核细胞中金属蛋白酶的亚细胞定位
Cells. 2018 Jul 20;7(7):80. doi: 10.3390/cells7070080.
3
Role of matrix metalloproteinases 2 and 9, toll-like receptor 4 and platelet-leukocyte aggregate formation in sepsis-associated thrombocytopenia.基质金属蛋白酶 2 和 9、 toll 样受体 4 及血小板-白细胞聚集体形成在脓毒症相关血小板减少症中的作用。
PLoS One. 2018 May 7;13(5):e0196478. doi: 10.1371/journal.pone.0196478. eCollection 2018.
4
MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.MMP - 2、MMP - 9、TIMP - 4与稳定型冠状动脉疾病的糖尿病和非糖尿病患者对阿司匹林的反应:一项初步研究
Biomed Res Int. 2017;2017:9352015. doi: 10.1155/2017/9352015. Epub 2017 Jul 10.
5
Streptococcus sanguinis-induced cytokine and matrix metalloproteinase-1 release from platelets.血链球菌诱导血小板释放细胞因子和基质金属蛋白酶-1
BMC Immunol. 2014 Apr 22;15:15. doi: 10.1186/1471-2172-15-15.